Ampio taps Daewoong as first partner for Zertane
This article was originally published in Scrip
Executive Summary
Ampio Pharmaceuticals has awarded exclusive marketing rights in South Korea to Zertane, its formulation of tramadol for premature ejaculation, to Daewoong Pharmaceuticals.